Literature DB >> 18057124

Beta-lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis Pharyngitis patients.

Vincenzo Savini1, Chiara Catavitello, Marzia Talia, Assunta Manna, Franca Pompetti, Giovanni Di Bonaventura, Nicola Di Giuseppe, Fabio Febbo, Andrea Balbinot, Silvia Di Zacomo, Francesca Esattore, Domenico D'Antonio.   

Abstract

We present two cases of exudative pharyngitis due to Streptococcus dysgalactiae subsp. equisimilis, Lancefield group G. While the participation of this organism as an agent of pharyngitis is well documented, we focus on failure of beta-lactam therapy, a phenomenon that is well described for pharyngitis due to Streptococcus pyogenes. Therefore, these case reports add to our knowledge of pharyngitis caused by non-S. pyogenes streptococci.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18057124      PMCID： PMC2238097          DOI： 10.1128/JCM.00985-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  32 in total

1.  Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America.

Authors:  Alan L Bisno; Michael A Gerber; Jack M Gwaltney; Edward L Kaplan; Richard H Schwartz
Journal:  Clin Infect Dis       Date:  2002-07-15       Impact factor: 9.079

2.  Pathogenic streptococci.

Authors:  C H RAMMELKAMP; J H DINGLE
Journal:  Annu Rev Microbiol       Date:  1948       Impact factor: 15.500

3.  ROLE of Lancefield groups of beta-hemolytic streptococci in respiratory infections.

Authors: 
Journal:  N Engl J Med       Date:  1947-01-30       Impact factor: 91.245

4.  Beta-haemolytic non-group A streptococci and pharyngitis: a case-control study.

Authors:  N Cimolai; B J Morrison; L MacCulloch; D F Smith; J Hlady
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

Review 5.  Why do we fail with penicillin in the treatment of group A streptococcus infections?

Authors:  S Sela; A Barzilai
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

6.  Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students.

Authors:  J C Turner; F G Hayden; M C Lobo; C E Ramirez; D Murren
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 7.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

Review 8.  Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies.

Authors:  M E Pichichero; J R Casey; T Mayes; A B Francis; S M Marsocci; A M Murphy; W Hoeger
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

9.  The Lancefield Groups of Hemolytic Streptococci Found in Children.

Authors:  E Estrada
Journal:  Yale J Biol Med       Date:  1940-03

10.  The role of group C and group G streptococci in acute pharyngitis in children.

Authors:  T Zaoutis; M Attia; R Gross; J Klein
Journal:  Clin Microbiol Infect       Date:  2004-01       Impact factor: 8.067
View more
  3 in total

1.  Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS).

Authors:  Yumi Shimomura; Kayo Okumura; Somay Yamagata Murayama; Junji Yagi; Kimiko Ubukata; Teruo Kirikae; Tohru Miyoshi-Akiyama
Journal:  BMC Genomics       Date:  2011-01-11       Impact factor: 3.969

2.  Pathologic and molecular characterization of Streptococcus dysgalactiae subsp. equisimilis infection in neonatal piglets.

Authors:  Sang-Ik Oh; Jong Wan Kim; Ji-Youl Jung; Myeongju Chae; Yu-Ran Lee; Jong Ho Kim; ByungJae So; Ha-Young Kim
Journal:  J Vet Sci       Date:  2018-03-31       Impact factor: 1.672

3.  Molecular subtyping and antimicrobial susceptibility of Streptococcus dysgalactiae subspecies equisimilis isolates from clinically diseased pigs.

Authors:  Sang Ik Oh; Jong Wan Kim; Jongho Kim; Byungjae So; Bumseok Kim; Ha Young Kim
Journal:  J Vet Sci       Date:  2020-07       Impact factor: 1.672
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.